Postpartum depression affects roughly one in five new mothers and remains chronically undertreated, particularly among minority and lower-resource populations. Understanding which women benefit most from preventive interventions — before symptoms become entrenched — could fundamentally reshape how health systems allocate mental health support during the perinatal period.
This preregistered subgroup analysis drew from a cluster-randomized trial of the Mothers and Babies (MB) program, a cognitive-behavioral and attachment-theory-based intervention delivered during pregnancy. Among 629 pregnant women with a mean gestational age of 22 weeks, participants completed the Quick Inventory of Depressive Symptomatology (QIDS) at baseline, post-intervention, and at 12 and 24 weeks postpartum. Using linear mixed models with three-way interaction terms, the analysis found that racial and ethnic minority participants showed meaningfully larger reductions in QIDS scores compared to non-minority participants, with a statistically significant interaction between minority status, study arm, and time (p = 0.048). First-time mothers receiving MB also demonstrated significantly lower depressive symptom scores at 24 weeks postpartum relative to multiparous women (p = 0.028). Language of intervention delivery and maternal education level did not produce significant differential effects.
These findings carry real clinical weight, though important caveats apply. Subgroup analyses — even when pre-specified — carry elevated Type I error risk and should be interpreted as hypothesis-generating rather than confirmatory. The trial was not powered specifically for subgroup detection, meaning some true differential effects may have gone undetected. That said, the MB program's stronger performance among minority participants is particularly noteworthy given that this group often faces compounded barriers to mental health care access. The first-time mother effect is biologically and psychologically plausible, given that primiparous women experience greater identity disruption and role transition stress. Overall, this analysis is incremental but directionally important — it suggests that universal preventive programs may not deliver uniform benefit and that tailoring or intensifying delivery for specific subgroups warrants further investigation in adequately powered trials.
